Lv3
250 积分 2022-02-28 加入
Adverse cardiovascular events in rheumatoid arthritis patients treated with JAK inhibitors: An analysis of postmarketing spontaneous safety reports
8个月前
已完结
Upadacitinib for the Treatment of Rheumatoid Arthritis: An Extensive Review
8个月前
已完结
Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician
8个月前
已完结
Comparative effectiveness of upadacitinib versus dupilumab for moderate-to-severe atopic dermatitis: A retrospective cohort study
9个月前
已完结
Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective study
9个月前
已完结
Comparative Effectiveness of Upadacitinib vs Ustekinumab for Ulcerative Colitis: A Multicenter Retrospective Cohort Study
9个月前
已完结
Real-world effectiveness and safety of upadacitinib for the treatment of atopic dermatitis in adult patients switched from dupilumab: A multicenter retrospective study
1年前
已完结
Efficacy and safety of filgotinib for ulcerative colitis: A real-world multicenter retrospective study in Japan
1年前
已完结
A Review of Dupilumab-Induced Adverse Events to Dermatologists and the Potential Pathogenesis in the Treatment of Atopic Dermatitis
1年前
已完结
Efficacy and safety of nemolizumab in paediatric patients aged 6-12 years with atopic dermatitis with moderate-to-severe pruritus: results from a phase III, randomized, double-blind, placebo-controlled, multicentre study
1年前
已完结
皖公网安备34019202002308
